Search

Your search keyword '"Karberg, Kirsten"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Karberg, Kirsten" Remove constraint Author: "Karberg, Kirsten" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
35 results on '"Karberg, Kirsten"'

Search Results

1. Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network

2. Aktuelle Zahlen zur rheumatologischen Versorgung – Jahresbericht aus der Kerndokumentation der regionalen kooperativen Rheumazentren

3. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices

6. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

8. Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database

9. Current data on rheumatological care: annual report from the National database (NDB) of the regional collaborative arthritis centres in Germany

10. Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres

11. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices

12. Rheuma- VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres.

13. Eine Applikation für die rheumatologische Versorgung: RheCORD

15. Standardpräsentation 2021

16. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis

17. Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study

18. Die 'ARIAA-Studie' – Abatacept verzögert den Übergang in eine RA bei at-risk-Patienten – klinische Ergebnisse zu Monat 18 der internationalen, randomisiert, placebo kontrollierten Studie

19. B cell characteristics and total numbers predict SARS-CoV-2 vaccination response among patients treated with rituximab

20. Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure

21. Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database

22. B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

23. B Cell Numbers Predict Humoral and Cellular Response Upon SARS – CoV ‐2 Vaccination Among Patients Treated With Rituximab

24. sj-docx-1-tab-10.1177_1759720X221085951 – Supplemental material for Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study

25. sj-docx-1-tab-10.1177_1759720X221114107 – Supplemental material for Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study

26. Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study

27. Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study

28. B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

29. Prevalence of Depressive Symptoms in Patients With Psoriatic Arthritis: Have Numbers Changed During the COVID-19 Pandemic?

30. Ist der RAID für entzündlich-rheumatische Erkrankungen ein aussagekräftiges Instrument?

31. Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure.

33. BENEFITS FROM a Plant-Based Diet, Intermittent Fasting and Aspects of Ayurvedic Nutrition IN Rheumatoid Arthritis – a Case Report

34. [With RheMIT rheumatology centers can participate in the German national database-Expansion of the long-term rheumatological documentation].

35. Persistent but atypical germinal center reaction among 3 rd SARS-CoV-2 vaccination after rituximab exposure.

Catalog

Books, media, physical & digital resources